KLOW
Also sold as KLOW blend, KLOW peptide blend
The same category of product as GLOW with a fourth peptide, KPV, generally added. The combination has never been tested in people either.
No clinical trial has tested this combination in people.
Not a small one, not an early-phase one, none. That is a statement about the blend, not about its ingredients, which have their own evidence and their own guides below.
Stated to contain
What sellers say is in it. Nobody standardises this, so treat it as a claim about a product rather than a specification. Each component has its own guide, and that is where its evidence is.
- KPVPreclinical
The three-residue anti-inflammatory tail of alpha-MSH, with consistent preclinical gut and skin data and no completed human trial.
- GHK-CuMechanistic
A copper-binding tripeptide with extensive in vitro data and modest topical cosmetic evidence. The gap between the gene-expression literature and what topical application does is very wide.
- BPC-157Preclinical
A 15-amino-acid sequence with a large, remarkably consistent animal literature, almost all of it from a small affiliated research network, and no completed human trial reporting results.
- Thymosin Beta-4 (TB-500)Early
A naturally occurring actin-binding peptide with genuine early clinical work in eye and wound indications. "TB-500" as sold is usually a fragment, not the full peptide, and the two are routinely conflated.
What it is
In shortKLOW is sold the same way GLOW is: a pre-mixed vial under a marketing name, positioned for skin, gut and recovery. It is usually described as GLOW with KPV added. Everything on the GLOW page about what a blend actually is applies here unchanged.
KLOW is sold the same way GLOW is: a pre-mixed vial under a marketing name, positioned for skin, gut and recovery. It is usually described as GLOW with KPV added, and the name is read as an initialism in the same way.
Everything on the GLOW page about what a blend is applies here without modification. This is a product name, not a molecule.
What is in it
In shortSellers generally say it contains KPV, GHK-Cu, BPC-157 and TB-500. The same caution applies and applies more, because there is one more ingredient to be wrong about. No standard defines KLOW and nobody independently checks what is in a vial.
Sellers generally state KLOW contains KPV, GHK-Cu, BPC-157 and TB-500.
The same caution applies and applies more, because there is one more ingredient to be wrong about. No standard defines KLOW, nothing stops two sellers shipping different mixtures under the name, and no independent party verifies any of it.
KPV is the addition relative to GLOW. It has its own guide here, and its evidence is animal work.
What has been tested
In shortNo human trial of this combination exists, and it is slightly worse off than GLOW. The registry returns nothing for KPV with BPC-157, and the published literature returns nothing either, so there is not even an animal study of a pairing that includes KPV.
There is no completed human trial of this combination, and the position is slightly worse than GLOW's rather than the same.
The trial registry returns nothing for KPV with BPC-157. The published literature returns nothing either: a search for the two together returns zero records, so unlike the GLOW pairings there is not even a rat study of the combination that includes KPV.
The single animal study relevant to any part of this blend remains the 2026 rat work on BPC-157 and TB-500 in Achilles tendon healing, which covers two of the four ingredients and no part of what KPV adds.
Safety
In shortEverything on the GLOW page applies, plus a fourth ingredient's risks and a fourth way to be unable to tell what did what. KPV damps inflammation, and long-term suppression has consequences for fighting infection that nobody has characterised, let alone combined with three other peptides.
Everything on the GLOW page applies, with a fourth component's risks added and a fourth way to be unable to attribute anything.
KPV is an anti-inflammatory in its proposed mechanism, and the general caution for anything that damps inflammation applies: sustained suppression has consequences for fighting infection and for immune surveillance, and nobody has characterised those for this compound, let alone for it combined with three others.
The attribution problem grows with each ingredient. With four peptides in one vial, a reaction cannot be traced and a benefit cannot be reproduced, which makes the thing unusable as evidence about itself.
Discuss it
The archive can tell you what has been tested. It cannot tell you what was in the vial somebody actually bought, and that is the question worth asking each other.
Blends in Protocol DiscussionFor Research & Educational Discussion Only. Not Medical Advice
This entry describes a product sold by third parties. Naming it is not a recommendation, a review, or a statement that it is available or lawful where you are. Nothing here is medical advice.